James M Beattie
James M Beattie publishes mostly in Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology, on topics such as Growth Hormone and Insulin-like Growth Factors, Heart Failure Treatment and Management and Palliative Care and End-of-Life Issues.
- World rank
- #2,555,457 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #179,838 of 367,258
- Works
- 215
- Citations
- 3.7k
- Citations per work
- 17.4
What does James M Beattie research?
James M Beattie's work is mostly in Medicine (39%), Biochemistry, Genetics and Molecular Biology (9%), Agricultural and Biological Sciences (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else10448.3%
- Health Sciences8439.3%
- Medicine8439.3%
- Life Sciences2712.4%
- 1Cardiology and Cardiovascular Medicine15% of their works
- 2Endocrinology, Diabetes and Metabolism12% of their works
- 3Molecular Biology8% of their works
- 4Public Health, Environmental and Occupational Health6% of their works
- 5Surgery5% of their works
- 6Plant Science4% of their works
Research topics
- Growth Hormone and Insulin-like Growth Factors
- Heart Failure Treatment and Management
- Palliative Care and End-of-Life Issues
- Metabolism, Diabetes, and Cancer
- Cardiac pacing and defibrillation studies
- Cancer, Hypoxia, and Metabolism
- Cardiac Structural Anomalies and Repair
- Mechanical Circulatory Support Devices
Which keywords describe James M Beattie's research?
The keywords of their largest research topics: Heart Failure, IGF-1, Insulin-like Growth Factors, Diagnosis, Guidelines, End-of-Life, Palliative Care and AMP-Activated Protein Kinase.
- Extracorporeal Membrane Oxygenation
- Ventricular Reconstruction
- HIF-1
- Cardiac Resynchronization Therapy
- AMP-Activated Protein Kinase
- End-of-Life
- Diagnosis
- IGF-1
- Heart Failure
- Insulin-like Growth Factors
- Guidelines
- Palliative Care
- Metformin
- Implantable Cardioverter-Defibrillator
- Myocardial Infarction
- Warburg Effect
- Left Ventricular Assist Device
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Heart Failure573 topics
- IGF-1541 topic
- Insulin-like Growth Factors541 topic
- Diagnosis331 topic
- Guidelines331 topic
- End-of-Life231 topic
- Palliative Care231 topic
- AMP-Activated Protein Kinase181 topic
- Metformin181 topic
- Cardiac Resynchronization Therapy141 topic
- Implantable Cardioverter-Defibrillator141 topic
- HIF-1121 topic
- Myocardial Infarction121 topic
- Ventricular Reconstruction121 topic
- Warburg Effect121 topic
- Extracorporeal Membrane Oxygenation101 topic
- Left Ventricular Assist Device101 topic
Where does James M Beattie work?
James M Beattie's main affiliation in the publication record is Hannah Research Foundation, United Kingdom.
How many publications and citations does James M Beattie have?
OpenAlex counts 215 works and 3,736 citations for James M Beattie, an h-index of 32, ranking #2,555,457 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about James M Beattie. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.